Last updated: 29 May 2022 at 5:05am EST

Henry McKinnell Net Worth




The estimated Net Worth of Henry A Mckinnell is at least $35.2 Million dollars as of 20 May 2022. Henry Mckinnell owns over 7,726 units of Moody`s stock worth over $34,816,944 and over the last 21 years he sold MCO stock worth over $0. In addition, he makes $414,955 as Independent Chairman of the Board at Moody`s.

Henry McKinnell MCO stock SEC Form 4 insiders trading

Henry has made over 9 trades of the Moody`s stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 7,726 units of MCO stock worth $3,697,586 on 20 May 2022.

The largest trade he's ever made was buying 334,728 units of Moody`s stock on 22 August 2016 worth over $987,448. On average, Henry trades about 4,880 units every 36 days since 2003. As of 20 May 2022 he still owns at least 72,749 units of Moody`s stock.

You can see the complete history of Henry Mckinnell stock trades at the bottom of the page.





Henry McKinnell biography

Dr. Henry A. McKinnell Jr., Ph.D. has been appointed as Independent Director of the Company effective 12/31/2020. Dr. McKinnell served as the Chief Executive Officer of Optimer Pharmaceuticals, Inc. from February 2013 until October 31, 2013. He served as Chairman of the Board of Pfizer Inc., a pharmaceutical company, from May 2001 until his retirement in December 2006 and Chief Executive Officer from January 2001 to July 2006. He served as President of Pfizer Inc. from May 1999 to May 2001, and as President of Pfizer Pharmaceuticals Group from January 1997 to April 2001. Dr. McKinnell served as Chief Operating Officer of Pfizer Inc. from May 1999 to December 2000 and as Executive Vice President from 1992 to 1999. He served as the Chairman of the Accordia Global Health Foundation, is Chairman Emeritus of the Connecticut Science Center and is Life Director of the Japan Society. He currently serves as a director of ChemoCentryx, Inc. He served as Chairman of Optimer Pharmaceuticals, Inc. until 2013 and Emmaus Life Sciences until 2015. He served as a director of Angiotech Pharmaceuticals, Inc. until 2011, Pfizer Inc. and ExxonMobil Corporation until 2007 and John Wiley & Sons until 2005. He also served as a director of ViewRay, Inc. from April 2016 to May 2019. Dr. McKinnell served for five years as the chief executive officer of a public pharmaceutical company with worldwide operations and, prior to that position, served as president, chief operating officer, chief financial officer and executive vice president. As a result of these positions, Dr. McKinnell brings to the Board financial expertise, global management experience and leadership skills. In addition, because the pharmaceutical business, like the Company’s, operates in a highly regulated industry, Dr. McKinnell brings to the Board an appreciation of what a complex regulatory environment means for the Company’s operations. Dr. McKinnell has also served as a director of several public companies, contributing to his perspective on corporate governance matter

What is the salary of Henry McKinnell?

As the Independent Chairman of the Board of Moody`s, the total compensation of Henry McKinnell at Moody`s is $414,955. There are 9 executives at Moody`s getting paid more, with Raymond McDaniel having the highest compensation of $13,751,600.



How old is Henry McKinnell?

Henry McKinnell is 77, he's been the Independent Chairman of the Board of Moody`s since 2012. There are no older and 21 younger executives at Moody`s.

What's Henry McKinnell's mailing address?

Henry's mailing address filed with the SEC is C/O CHEMOCENTRYX, INC., 835 INDUSTRIAL ROAD, SUITE 600, SAN CARLOS, CA, 94070.

Insiders trading at Moody`s

Over the last 21 years, insiders at Moody`s have traded over $878,420,300 worth of Moody`s stock and bought 8,915 units worth $547,914 . The most active insiders traders include Hathaway Incbuffett Warren ..., Corp /De/ Moodys, and Hathaway Incbuffett Warren .... On average, Moody`s executives and independent directors trade stock every 21 days with the average trade being worth of $38,079,013. The most recent stock trade was executed by Stephen T Tulenko on 9 August 2024, trading 500 units of MCO stock currently worth $232,030.



What does Moody`s do?

moody's is an essential component of the global capital markets, providing credit ratings, research, tools and analysis that contribute to transparent and integrated financial markets. moody's corporation (nyse: mco) is the parent company of moody's investors service, which provides credit ratings and research covering debt instruments and securities, and moody's analytics, which offers leading-edge software, advisory services and research for credit and economic analysis and financial risk management. the corporation, which reported revenue of $3.3 billion in 2014, employs approximately 9,900 people worldwide and maintains a presence in 33 countries. further information is available at www.moodys.com.



Complete history of Henry Mckinnell stock trades at ChemoCentryx Inc, ViewRay, Exxon Mobil, and Moody`s

Insider
Trans.
Transaction
Total value
Henry A Mckinnell
Director
Option $176,076
20 May 2022
Henry A Mckinnell
Director
Option $99,873
21 May 2019
Henry A Mckinnell
Director
Buy $992,175
18 Jan 2017
Henry A Mckinnell
Director
Buy $987,448
22 Aug 2016
Henry A Mckinnell
Director
Option $287,856
17 Nov 2011
Henry A Mckinnell
Director
Option $303,696
21 May 2010
Henry A Mckinnell
Director
Option $109,900
29 Sep 2009
Henry A Mckinnell
Director
Option $66,360
6 Nov 2008
Henry A Mckinnell
Director
Option $68,306
30 Oct 2007


Moody`s executives and stock owners

Moody`s executives and other stock owners filed with the SEC include: